Loomis Sayles & Co. L P boosted its holdings in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 8.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 305,492 shares of the company's stock after purchasing an additional 22,815 shares during the period. Loomis Sayles & Co. L P owned about 0.47% of Concentrix worth $15,657,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CNXC. 1832 Asset Management L.P. bought a new position in shares of Concentrix in the second quarter valued at approximately $62,738,000. Pzena Investment Management LLC raised its stake in shares of Concentrix by 46.6% in the second quarter. Pzena Investment Management LLC now owns 1,484,907 shares of the company's stock valued at $93,965,000 after acquiring an additional 471,699 shares during the last quarter. Paradigm Capital Management Inc. NY raised its stake in shares of Concentrix by 126.4% in the second quarter. Paradigm Capital Management Inc. NY now owns 623,542 shares of the company's stock valued at $39,458,000 after acquiring an additional 348,100 shares during the last quarter. AQR Capital Management LLC raised its stake in shares of Concentrix by 74.4% in the second quarter. AQR Capital Management LLC now owns 813,864 shares of the company's stock valued at $51,160,000 after acquiring an additional 347,230 shares during the last quarter. Finally, Marshall Wace LLP bought a new position in shares of Concentrix in the second quarter valued at approximately $6,852,000. Institutional investors own 90.34% of the company's stock.
Concentrix Trading Up 0.8 %
CNXC traded up $0.36 during trading on Wednesday, reaching $44.92. 653,190 shares of the company's stock were exchanged, compared to its average volume of 577,291. The company's fifty day moving average price is $47.23 and its 200-day moving average price is $59.22. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.57 and a current ratio of 1.57. Concentrix Co. has a fifty-two week low of $36.28 and a fifty-two week high of $106.10. The firm has a market capitalization of $2.91 billion, a PE ratio of 14.58, a P/E/G ratio of 0.61 and a beta of 0.61.
Concentrix (NASDAQ:CNXC - Get Free Report) last announced its quarterly earnings results on Wednesday, September 25th. The company reported $2.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.93 by ($0.06). Concentrix had a net margin of 2.18% and a return on equity of 16.57%. The firm had revenue of $2.39 billion during the quarter, compared to analyst estimates of $2.38 billion. During the same period last year, the firm earned $2.54 EPS. Concentrix's quarterly revenue was up 46.2% on a year-over-year basis. As a group, equities analysts forecast that Concentrix Co. will post 10.18 EPS for the current year.
Concentrix Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, November 5th. Stockholders of record on Friday, October 25th were issued a $0.333 dividend. This is a positive change from Concentrix's previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, October 25th. This represents a $1.33 annualized dividend and a dividend yield of 2.97%. Concentrix's payout ratio is 43.18%.
Insider Activity
In related news, EVP Cormac J. Twomey sold 400 shares of the business's stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $74.63, for a total value of $29,852.00. Following the sale, the executive vice president now directly owns 29,327 shares of the company's stock, valued at approximately $2,188,674.01. The trade was a 1.35 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Christopher A. Caldwell sold 9,823 shares of the business's stock in a transaction on Friday, October 4th. The shares were sold at an average price of $52.70, for a total transaction of $517,672.10. Following the completion of the sale, the chief executive officer now directly owns 241,841 shares in the company, valued at $12,745,020.70. This represents a 3.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 12,267 shares of company stock valued at $648,945 in the last quarter. Company insiders own 3.10% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on CNXC. Bank of America cut their target price on shares of Concentrix from $85.00 to $70.00 and set a "neutral" rating for the company in a research note on Thursday, September 26th. Baird R W upgraded shares of Concentrix to a "strong-buy" rating in a research report on Thursday, October 3rd. Canaccord Genuity Group dropped their price objective on shares of Concentrix from $125.00 to $100.00 and set a "buy" rating for the company in a research report on Thursday, September 26th. Barrington Research dropped their price objective on shares of Concentrix from $84.00 to $70.00 and set an "outperform" rating for the company in a research report on Thursday, September 26th. Finally, Robert W. Baird started coverage on shares of Concentrix in a research report on Thursday, October 3rd. They issued an "outperform" rating and a $70.00 price objective for the company. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $79.00.
Read Our Latest Stock Report on Concentrix
Concentrix Company Profile
(
Free Report)
Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.
Read More
Before you consider Concentrix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.
While Concentrix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.